Inventiveness in peptide drug technology and a well thought-
out business strategy characterize PeptiDream’s thriving growth.
Venture Valuation (VV) interviewed Kiichi Kubota, co-founder and
Chairman.
Inventiveness in peptide drug technology and a well thought-
out business strategy characterize PeptiDream’s thriving growth.
Venture Valuation (VV) interviewed Kiichi Kubota, co-founder and
Chairman.